Global Transdermal Drug Patches Market Growth 2021-2026


Jul, 2021 | Report ID: 204317 | 108 | Pharmaceuticals and Healthcare

According to this latest study, the 2021 growth of Transdermal Drug Patches will have significant change from previous year. By the most conservative estimates of global Transdermal Drug Patches market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Transdermal Drug Patches market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Transdermal Drug Patches market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.

Fentanyl Transdermal Patch

Nicotine Transdermal Patch

Buprenorphine Transdermal Patch

Clonidine Transdermal Patch

Oxybutynin Transdermal Patch

Others

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.

Hypertension

Contraception

Analgesia

Smoking Cessation

Angina

Hormone Replacement

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.

Noven

Mylan

Novartis

Johnson & Johnson

Agile Therapeutics

Teikoku Pharma USA

Immune Pharmaceuticals

Hercon Pharmaceuticals

Pocono

DURECT Corporation

Xel Pharmaceuticals


Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Transdermal Drug Patches Consumption 2016-2026

2.1.2 Transdermal Drug Patches Consumption CAGR by Region

2.2 Transdermal Drug Patches Segment by Type

2.2.1 Fentanyl Transdermal Patch

2.2.2 Nicotine Transdermal Patch

2.2.3 Buprenorphine Transdermal Patch

2.2.4 Clonidine Transdermal Patch

2.2.5 Oxybutynin Transdermal Patch

2.2.6 Others

2.3 Transdermal Drug Patches Sales by Type

2.3.1 Global Transdermal Drug Patches Sales Market Share by Type (2016-2021)

2.3.2 Global Transdermal Drug Patches Revenue and Market Share by Type (2016-2021)

2.3.3 Global Transdermal Drug Patches Sale Price by Type (2016-2021)

2.4 Transdermal Drug Patches Segment by Application

2.4.1 Hypertension

2.4.2 Contraception

2.4.3 Analgesia

2.4.4 Smoking Cessation

2.4.5 Angina

2.4.6 Hormone Replacement

2.5 Transdermal Drug Patches Sales by Application

2.5.1 Global Transdermal Drug Patches Sale Market Share by Application (2016-2021)

2.5.2 Global Transdermal Drug Patches Revenue and Market Share by Application (2016-2021)

2.5.3 Global Transdermal Drug Patches Sale Price by Application (2016-2021)

3 Global Transdermal Drug Patches by Company

3.1 Global Transdermal Drug Patches Sales Market Share by Company

3.1.1 Global Transdermal Drug Patches Sales by Company (2019-2021)

3.1.2 Global Transdermal Drug Patches Sales Market Share by Company (2019-2021)

3.2 Global Transdermal Drug Patches Revenue Market Share by Company

3.2.1 Global Transdermal Drug Patches Revenue by Company (2019-2021)

3.2.2 Global Transdermal Drug Patches Revenue Market Share by Company (2019-2021)

3.3 Global Transdermal Drug Patches Sale Price by Company

3.4 Global Manufacturers Transdermal Drug Patches Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Transdermal Drug Patches Product Location Distribution

3.4.2 Players Transdermal Drug Patches Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Transdermal Drug Patches by Region

4.1 Global Transdermal Drug Patches by Region

4.1.1 Global Transdermal Drug Patches Sales by Region

4.1.2 Global Transdermal Drug Patches Revenue by Region

4.2 Americas Transdermal Drug Patches Sales Growth

4.3 APAC Transdermal Drug Patches Sales Growth

4.4 Europe Transdermal Drug Patches Sales Growth

4.5 Middle East & Africa Transdermal Drug Patches Sales Growth

5 Americas

5.1 Americas Transdermal Drug Patches Sales by Country

5.1.1 Americas Transdermal Drug Patches Sales by Country (2016-2021)

5.1.2 Americas Transdermal Drug Patches Revenue by Country (2016-2021)

5.2 Americas Transdermal Drug Patches Sales by Type

5.3 Americas Transdermal Drug Patches Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Transdermal Drug Patches Sales by Region

6.1.1 APAC Transdermal Drug Patches Sales by Region (2016-2021)

6.1.2 APAC Transdermal Drug Patches Revenue by Region (2016-2021)

6.2 APAC Transdermal Drug Patches Sales by Type

6.3 APAC Transdermal Drug Patches Sales by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Transdermal Drug Patches by Country

7.1.1 Europe Transdermal Drug Patches Sales by Country (2016-2021)

7.1.2 Europe Transdermal Drug Patches Revenue by Country (2016-2021)

7.2 Europe Transdermal Drug Patches Sales by Type

7.3 Europe Transdermal Drug Patches Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Transdermal Drug Patches by Country

8.1.1 Middle East & Africa Transdermal Drug Patches Sales by Country (2016-2021)

8.1.2 Middle East & Africa Transdermal Drug Patches Revenue by Country (2016-2021)

8.2 Middle East & Africa Transdermal Drug Patches Sales by Type

8.3 Middle East & Africa Transdermal Drug Patches Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Country

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Transdermal Drug Patches Distributors

10.3 Transdermal Drug Patches Customer

11 Global Transdermal Drug Patches Market Forecast

11.1 Global Transdermal Drug Patches Forecast by Region

11.1.1 Global Transdermal Drug Patches Forecast by Regions (2021-2026)

11.2.2 Global Transdermal Drug Patches Revenue Forecast by Regions (2021-2026)

11.2 Americas Forecast by Country

11.3 APAC Forecast by Region

11.4 Europe Forecast by Country

11.5 Middle East & Africa Forecast by Country

11.6 Global Transdermal Drug Patches Forecast by Type

11.7 Global Transdermal Drug Patches Forecast by Application

12 Key Players Analysis

12.1 Noven

12.1.1 Noven Company Information

12.1.2 Noven Transdermal Drug Patches Product Offered

12.1.3 Noven Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2019-2021)

12.1.4 Noven Main Business Overview

12.1.5 Noven Latest Developments

12.2 Mylan

12.2.1 Mylan Company Information

12.2.2 Mylan Transdermal Drug Patches Product Offered

12.2.3 Mylan Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2019-2021)

12.2.4 Mylan Main Business Overview

12.2.5 Mylan Latest Developments

12.3 Novartis

12.3.1 Novartis Company Information

12.3.2 Novartis Transdermal Drug Patches Product Offered

12.3.3 Novartis Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2019-2021)

12.3.4 Novartis Main Business Overview

12.3.5 Novartis Latest Developments

12.4 Johnson & Johnson

12.4.1 Johnson & Johnson Company Information

12.4.2 Johnson & Johnson Transdermal Drug Patches Product Offered

12.4.3 Johnson & Johnson Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2019-2021)

12.4.4 Johnson & Johnson Main Business Overview

12.4.5 Johnson & Johnson Latest Developments

12.5 Agile Therapeutics

12.5.1 Agile Therapeutics Company Information

12.5.2 Agile Therapeutics Transdermal Drug Patches Product Offered

12.5.3 Agile Therapeutics Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2019-2021)

12.5.4 Agile Therapeutics Main Business Overview

12.5.5 Agile Therapeutics Latest Developments

12.6 Teikoku Pharma USA

12.6.1 Teikoku Pharma USA Company Information

12.6.2 Teikoku Pharma USA Transdermal Drug Patches Product Offered

12.6.3 Teikoku Pharma USA Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2019-2021)

12.6.4 Teikoku Pharma USA Main Business Overview

12.6.5 Teikoku Pharma USA Latest Developments

12.7 Immune Pharmaceuticals

12.7.1 Immune Pharmaceuticals Company Information

12.7.2 Immune Pharmaceuticals Transdermal Drug Patches Product Offered

12.7.3 Immune Pharmaceuticals Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2019-2021)

12.7.4 Immune Pharmaceuticals Main Business Overview

12.7.5 Immune Pharmaceuticals Latest Developments

12.8 Hercon Pharmaceuticals

12.8.1 Hercon Pharmaceuticals Company Information

12.8.2 Hercon Pharmaceuticals Transdermal Drug Patches Product Offered

12.8.3 Hercon Pharmaceuticals Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2019-2021)

12.8.4 Hercon Pharmaceuticals Main Business Overview

12.8.5 Hercon Pharmaceuticals Latest Developments

12.9 Pocono

12.9.1 Pocono Company Information

12.9.2 Pocono Transdermal Drug Patches Product Offered

12.9.3 Pocono Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2019-2021)

12.9.4 Pocono Main Business Overview

12.9.5 Pocono Latest Developments

12.10 DURECT Corporation

12.10.1 DURECT Corporation Company Information

12.10.2 DURECT Corporation Transdermal Drug Patches Product Offered

12.10.3 DURECT Corporation Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2019-2021)

12.10.4 DURECT Corporation Main Business Overview

12.10.5 DURECT Corporation Latest Developments

12.11 Xel Pharmaceuticals

12.11.1 Xel Pharmaceuticals Company Information

12.11.2 Xel Pharmaceuticals Transdermal Drug Patches Product Offered

12.11.3 Xel Pharmaceuticals Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2019-2021)

12.11.4 Xel Pharmaceuticals Main Business Overview

12.11.5 Xel Pharmaceuticals Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Transdermal Drug Patches Consumption CAGR by Region (2020-2026) & ($ Millions)

Table 2. Major Players of Fentanyl Transdermal Patch

Table 3. Major Players of Nicotine Transdermal Patch

Table 4. Major Players of Buprenorphine Transdermal Patch

Table 5. Major Players of Clonidine Transdermal Patch

Table 6. Major Players of Oxybutynin Transdermal Patch

Table 7. Major Players of Others

Table 8. Global Transdermal Drug Patches Sales by Type (2016-2021) & (K Units)

Table 9. Global Transdermal Drug Patches Sales Market Share by Type (2016-2021)

Table 10. Global Transdermal Drug Patches Revenue by Type (2016-2021) & ($ million)

Table 11. Global Transdermal Drug Patches Revenue Market Share by Type (2016-2021)

Table 12. Global Transdermal Drug Patches Sale Price by Type (2016-2021)

Table 13. Global Transdermal Drug Patches Sales by Application (2016-2021) & (K Units)

Table 14. Global Transdermal Drug Patches Sales Market Share by Application (2016-2021)

Table 15. Global Transdermal Drug Patches Value by Application (2016-2021)

Table 16. Global Transdermal Drug Patches Revenue Market Share by Application (2016-2021)

Table 17. Global Transdermal Drug Patches Sale Price by Application (2016-2021)

Table 18. Global Transdermal Drug Patches Sales by Company (2019-2021) & (K Units)

Table 19. Global Transdermal Drug Patches Sales Market Share by Company (2019-2021)

Table 20. Global Transdermal Drug Patches Revenue by Company (2019-2021) ($ Millions)

Table 21. Global Transdermal Drug Patches Revenue Market Share by Company (2019-2021)

Table 22. Global Transdermal Drug Patches Sale Price by Company (2019-2021)

Table 23. Key Manufacturers Transdermal Drug Patches Producing Area Distribution and Sales Area

Table 24. Players Transdermal Drug Patches Products Offered

Table 25. Transdermal Drug Patches Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

Table 26. New Products and Potential Entrants

Table 27. Mergers & Acquisitions, Expansion

Table 28. Global Transdermal Drug Patches Sales by Region (2016-2021) (K Units)

Table 29. Global Transdermal Drug Patches Sales Market Share by Region (2016-2021)

Table 30. Global Transdermal Drug Patches Revenue by Region (2016-2021) & ($ Millions)

Table 31. Global Transdermal Drug Patches Revenue Market Share by Region (2016-2021)

Table 32. Americas Transdermal Drug Patches Sales by Country (2016-2021) & (K Units)

Table 33. Americas Transdermal Drug Patches Sales Market Share by Country (2016-2021)

Table 34. Americas Transdermal Drug Patches Revenue by Country (2016-2021) & ($ Millions)

Table 35. Americas Transdermal Drug Patches Revenue Market Share by Country (2016-2021)

Table 36. Americas Transdermal Drug Patches Sales by Type (2016-2021) & (K Units)

Table 37. Americas Transdermal Drug Patches Sales Market Share by Type (2016-2021)

Table 38. Americas Transdermal Drug Patches Sales by Application (2016-2021) & (K Units)

Table 39. Americas Transdermal Drug Patches Sales Market Share by Application (2016-2021)

Table 40. APAC Transdermal Drug Patches Sales by Region (2016-2021) & (K Units)

Table 41. APAC Transdermal Drug Patches Sales Market Share by Region (2016-2021)

Table 42. APAC Transdermal Drug Patches Revenue by Region (2016-2021) & ($ Millions)

Table 43. APAC Transdermal Drug Patches Revenue Market Share by Region (2016-2021)

Table 44. APAC Transdermal Drug Patches Sales by Type (2016-2021) & (K Units)

Table 45. APAC Transdermal Drug Patches Sales Market Share by Type (2016-2021)

Table 46. APAC Transdermal Drug Patches Sales by Application (2016-2021) & (K Units)

Table 47. APAC Transdermal Drug Patches Sales Market Share by Application (2016-2021)

Table 48. Europe Transdermal Drug Patches Sales by Country (2016-2021) & (K Units)

Table 49. Europe Transdermal Drug Patches Sales Market Share by Country (2016-2021)

Table 50. Europe Transdermal Drug Patches Revenue by Country (2016-2021) & ($ Millions)

Table 51. Europe Transdermal Drug Patches Revenue Market Share by Country (2016-2021)

Table 52. Europe Transdermal Drug Patches Sales by Type (2016-2021) & (K Units)

Table 53. Europe Transdermal Drug Patches Sales Market Share by Type (2016-2021)

Table 54. Europe Transdermal Drug Patches Sales by Application (2016-2021) & (K Units)

Table 55. Europe Transdermal Drug Patches Sales Market Share by Application (2016-2021)

Table 56. Middle East & Africa Transdermal Drug Patches Sales by Country (2016-2021) & (K Units)

Table 57. Middle East & Africa Transdermal Drug Patches Sales Market Share by Country (2016-2021)

Table 58. Middle East & Africa Transdermal Drug Patches Revenue by Country (2016-2021) & ($ Millions)

Table 59. Middle East & Africa Transdermal Drug Patches Revenue Market Share by Country (2016-2021)

Table 60. Middle East & Africa Transdermal Drug Patches Sales by Type (2016-2021) & (K Units)

Table 61. Middle East & Africa Transdermal Drug Patches Sales Market Share by Type (2016-2021)

Table 62. Middle East & Africa Transdermal Drug Patches Sales by Application (2016-2021) & (K Units)

Table 63. Middle East & Africa Transdermal Drug Patches Sales Market Share by Application (2016-2021)

Table 64. Key and Potential Regions of Transdermal Drug Patches

Table 65. Key Application and Potential Industries of Transdermal Drug Patches

Table 66. Key Challenges of Transdermal Drug Patches

Table 67. Key Trends of Transdermal Drug Patches

Table 68. Transdermal Drug Patches Distributors List

Table 69. Transdermal Drug Patches Customer List

Table 70. Global Transdermal Drug Patches Sales Forecast by Region (2021-2026) & (K Units)

Table 71. Global Transdermal Drug Patches Consumption Market Forecast by Region

Table 72. Global Transdermal Drug Patches Revenue Forecast by Region (2021-2026) & ($ millions)

Table 73. Global Transdermal Drug Patches Revenue Market Share Forecast by Region (2021-2026)

Table 74. Americas Transdermal Drug Patches Sales Forecast by Country (2021-2026) & (K Units)

Table 75. Americas Transdermal Drug Patches Revenue Forecast by Country (2021-2026) & ($ millions)

Table 76. APAC Transdermal Drug Patches Sales Forecast by Region (2021-2026) & (K Units)

Table 77. APAC Transdermal Drug Patches Revenue Forecast by Region (2021-2026) & ($ millions)

Table 78. Europe Transdermal Drug Patches Sales Forecast by Country (2021-2026) & (K Units)

Table 79. Europe Transdermal Drug Patches Revenue Forecast by Country (2021-2026) & ($ millions)

Table 80. Middle East & Africa Transdermal Drug Patches Sales Forecast by Country (2021-2026) & (K Units)

Table 81. Middle East & Africa Transdermal Drug Patches Revenue Forecast by Country (2021-2026) & ($ millions)

Table 82. Global Transdermal Drug Patches Sales Forecast by Type (2021-2026) & (K Units)

Table 83. Global Transdermal Drug Patches Sales Market Share Forecast by Type (2021-2026)

Table 84. Global Transdermal Drug Patches Revenue Forecast by Type (2021-2026) & ($ Millions)

Table 85. Global Transdermal Drug Patches Revenue Market Share Forecast by Type (2021-2026)

Table 86. Global Transdermal Drug Patches Sales Forecast by Application (2021-2026) & (K Units)

Table 87. Global Transdermal Drug Patches Sales Market Share Forecast by Application (2021-2026)

Table 88. Global Transdermal Drug Patches Revenue Forecast by Application (2021-2026) & ($ Millions)

Table 89. Global Transdermal Drug Patches Revenue Market Share Forecast by Application (2021-2026)

Table 90. Noven Basic Information, Transdermal Drug Patches Manufacturing Base, Sales Area and Its Competitors

Table 91. Noven Transdermal Drug Patches Product Offered

Table 92. Noven Transdermal Drug Patches Sales (K Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2019-2021E)

Table 93. Noven Main Business

Table 94. Noven Latest Developments

Table 95. Mylan Basic Information, Transdermal Drug Patches Manufacturing Base, Sales Area and Its Competitors

Table 96. Mylan Transdermal Drug Patches Product Offered

Table 97. Mylan Transdermal Drug Patches Sales (K Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2019-2021E)

Table 98. Mylan Main Business

Table 99. Mylan Latest Developments

Table 100. Novartis Basic Information, Transdermal Drug Patches Manufacturing Base, Sales Area and Its Competitors

Table 101. Novartis Transdermal Drug Patches Product Offered

Table 102. Novartis Transdermal Drug Patches Sales (K Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2019-2021E)

Table 103. Novartis Main Business

Table 104. Novartis Latest Developments

Table 105. Johnson & Johnson Basic Information, Transdermal Drug Patches Manufacturing Base, Sales Area and Its Competitors

Table 106. Johnson & Johnson Transdermal Drug Patches Product Offered

Table 107. Johnson & Johnson Transdermal Drug Patches Sales (K Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2019-2021E)

Table 108. Johnson & Johnson Main Business

Table 109. Johnson & Johnson Latest Developments

Table 110. Agile Therapeutics Basic Information, Transdermal Drug Patches Manufacturing Base, Sales Area and Its Competitors

Table 111. Agile Therapeutics Transdermal Drug Patches Product Offered

Table 112. Agile Therapeutics Transdermal Drug Patches Sales (K Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2019-2021E)

Table 113. Agile Therapeutics Main Business

Table 114. Agile Therapeutics Latest Developments

Table 115. Teikoku Pharma USA Basic Information, Transdermal Drug Patches Manufacturing Base, Sales Area and Its Competitors

Table 116. Teikoku Pharma USA Transdermal Drug Patches Product Offered

Table 117. Teikoku Pharma USA Transdermal Drug Patches Sales (K Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2019-2021E)

Table 118. Teikoku Pharma USA Main Business

Table 119. Teikoku Pharma USA Latest Developments

Table 120. Immune Pharmaceuticals Basic Information, Transdermal Drug Patches Manufacturing Base, Sales Area and Its Competitors

Table 121. Immune Pharmaceuticals Transdermal Drug Patches Product Offered

Table 122. Immune Pharmaceuticals Transdermal Drug Patches Sales (K Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2019-2021E)

Table 123. Immune Pharmaceuticals Main Business

Table 124. Immune Pharmaceuticals Latest Developments

Table 125. Hercon Pharmaceuticals Basic Information, Transdermal Drug Patches Manufacturing Base, Sales Area and Its Competitors

Table 126. Hercon Pharmaceuticals Transdermal Drug Patches Product Offered

Table 127. Hercon Pharmaceuticals Transdermal Drug Patches Sales (K Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2019-2021E)

Table 128. Hercon Pharmaceuticals Main Business

Table 129. Hercon Pharmaceuticals Latest Developments

Table 130. Pocono Basic Information, Transdermal Drug Patches Manufacturing Base, Sales Area and Its Competitors

Table 131. Pocono Transdermal Drug Patches Product Offered

Table 132. Pocono Transdermal Drug Patches Sales (K Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2019-2021E)

Table 133. Pocono Main Business

Table 134. Pocono Latest Developments

Table 135. DURECT Corporation Basic Information, Transdermal Drug Patches Manufacturing Base, Sales Area and Its Competitors

Table 136. DURECT Corporation Transdermal Drug Patches Product Offered

Table 137. DURECT Corporation Transdermal Drug Patches Sales (K Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2019-2021E)

Table 138. DURECT Corporation Main Business

Table 139. DURECT Corporation Latest Developments

Table 140. Xel Pharmaceuticals Basic Information, Transdermal Drug Patches Manufacturing Base, Sales Area and Its Competitors

Table 141. Xel Pharmaceuticals Transdermal Drug Patches Product Offered

Table 142. Xel Pharmaceuticals Transdermal Drug Patches Sales (K Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2019-2021E)

Table 143. Xel Pharmaceuticals Main Business

Table 144. Xel Pharmaceuticals Latest Developments

List of Figures

Figure 1. Picture of Transdermal Drug Patches

Figure 2. Transdermal Drug Patches Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Transdermal Drug Patches Sales Growth Rate 2016-2026 (K Units)

Figure 7. Global Transdermal Drug Patches Revenue Growth Rate 2016-2026 ($ Millions)

Figure 8. Transdermal Drug Patches Sales by Region (2021 & 2026) & ($ millions)

Figure 9. Product Picture of Fentanyl Transdermal Patch

Figure 10. Product Picture of Nicotine Transdermal Patch

Figure 11. Product Picture of Buprenorphine Transdermal Patch

Figure 12. Product Picture of Clonidine Transdermal Patch

Figure 13. Product Picture of Oxybutynin Transdermal Patch

Figure 14. Product Picture of Others

Figure 15. Global Transdermal Drug Patches Sales Market Share by Type in 2020

Figure 16. Global Transdermal Drug Patches Revenue Market Share by Type (2016-2021)

Figure 17. Transdermal Drug Patches Consumed in Hypertension

Figure 18. Global Transdermal Drug Patches Market: Hypertension (2016-2021) & (K Units)

Figure 19. Transdermal Drug Patches Consumed in Contraception

Figure 20. Global Transdermal Drug Patches Market: Contraception (2016-2021) & (K Units)

Figure 21. Transdermal Drug Patches Consumed in Analgesia

Figure 22. Global Transdermal Drug Patches Market: Analgesia (2016-2021) & (K Units)

Figure 23. Transdermal Drug Patches Consumed in Smoking Cessation

Figure 24. Global Transdermal Drug Patches Market: Smoking Cessation (2016-2021) & (K Units)

Figure 25. Transdermal Drug Patches Consumed in Angina

Figure 26. Global Transdermal Drug Patches Market: Angina (2016-2021) & (K Units)

Figure 27. Transdermal Drug Patches Consumed in Hormone Replacement

Figure 28. Global Transdermal Drug Patches Market: Hormone Replacement (2016-2021) & (K Units)

Figure 29. Global Transdermal Drug Patches Sales Market Share by Application (2016-2021)

Figure 30. Global Transdermal Drug Patches Revenue Market Share by Application in 2020

Figure 31. Transdermal Drug Patches Revenue Market by Company in 2020 ($ Million)

Figure 32. Global Transdermal Drug Patches Revenue Market Share by Company in 2020

Figure 33. Global Transdermal Drug Patches Sales Market Share by Regions (2016-2021)

Figure 34. Global Transdermal Drug Patches Revenue Market Share by Region in 2020

Figure 35. Americas Transdermal Drug Patches Sales 2016-2021 (K Units)

Figure 36. Americas Transdermal Drug Patches Revenue 2016-2021 ($ Millions)

Figure 37. APAC Transdermal Drug Patches Sales 2016-2021 (K Units)

Figure 38. APAC Transdermal Drug Patches Revenue 2016-2021 ($ Millions)

Figure 39. Europe Transdermal Drug Patches Sales 2016-2021 (K Units)

Figure 40. Europe Transdermal Drug Patches Revenue 2016-2021 ($ Millions)

Figure 41. Middle East & Africa Transdermal Drug Patches Sales 2016-2021 (K Units)

Figure 42. Middle East & Africa Transdermal Drug Patches Revenue 2016-2021 ($ Millions)

Figure 43. Americas Transdermal Drug Patches Sales Market Share by Country in 2020

Figure 44. Americas Transdermal Drug Patches Revenue Market Share by Country in 2020

Figure 45. Americas Transdermal Drug Patches Sales Market Share by Type in 2020

Figure 46. Americas Transdermal Drug Patches Sales Market Share by Application in 2020

Figure 47. United States Transdermal Drug Patches Revenue Growth 2016-2021 ($ Millions)

Figure 48. Canada Transdermal Drug Patches Revenue Growth 2016-2021 ($ Millions)

Figure 49. Mexico Transdermal Drug Patches Revenue Growth 2016-2021 ($ Millions)

Figure 50. Brazil Transdermal Drug Patches Revenue Growth 2016-2021 ($ Millions)

Figure 51. APAC Transdermal Drug Patches Sales Market Share by Region in 2020

Figure 52. APAC Transdermal Drug Patches Revenue Market Share by Regions in 2020

Figure 53. APAC Transdermal Drug Patches Sales Market Share by Type in 2020

Figure 54. APAC Transdermal Drug Patches Sales Market Share by Application in 2020

Figure 55. China Transdermal Drug Patches Revenue Growth 2016-2021 ($ Millions)

Figure 56. Japan Transdermal Drug Patches Revenue Growth 2016-2021 ($ Millions)

Figure 57. Korea Transdermal Drug Patches Revenue Growth 2016-2021 ($ Millions)

Figure 58. Southeast Asia Transdermal Drug Patches Revenue Growth 2016-2021 ($ Millions)

Figure 59. India Transdermal Drug Patches Revenue Growth 2016-2021 ($ Millions)

Figure 60. Australia Transdermal Drug Patches Revenue Growth 2016-2021 ($ Millions)

Figure 61. Europe Transdermal Drug Patches Sales Market Share by Country in 2020

Figure 62. Europe Transdermal Drug Patches Revenue Market Share by Country in 2020

Figure 63. Europe Transdermal Drug Patches Sales Market Share by Type in 2020

Figure 64. Europe Transdermal Drug Patches Sales Market Share by Application in 2020

Figure 65. Germany Transdermal Drug Patches Revenue Growth 2016-2021 ($ Millions)

Figure 66. France Transdermal Drug Patches Revenue Growth 2016-2021 ($ Millions)

Figure 67. UK Transdermal Drug Patches Revenue Growth 2016-2021 ($ Millions)

Figure 68. Italy Transdermal Drug Patches Revenue Growth 2016-2021 ($ Millions)

Figure 69. Russia Transdermal Drug Patches Revenue Growth 2016-2021 ($ Millions)

Figure 70. Middle East & Africa Transdermal Drug Patches Sales Market Share by Country in 2020

Figure 71. Middle East & Africa Transdermal Drug Patches Revenue Market Share by Country in 2020

Figure 72. Middle East & Africa Transdermal Drug Patches Sales Market Share by Type in 2020

Figure 73. Middle East & Africa Transdermal Drug Patches Sales Market Share by Application in 2020

Figure 74. Egypt Transdermal Drug Patches Revenue Growth 2016-2021 ($ Millions)

Figure 75. South Africa Transdermal Drug Patches Revenue Growth 2016-2021 ($ Millions)

Figure 76. Israel Transdermal Drug Patches Revenue Growth 2016-2021 ($ Millions)

Figure 77. Turkey Transdermal Drug Patches Revenue Growth 2016-2021 ($ Millions)

Figure 78. GCC Country Transdermal Drug Patches Revenue Growth 2016-2021 ($ Millions)

Figure 79. Channels of Distribution

Figure 80. Distributors Profiles

Sample Request is not available